Norges Bank Makes New $49.09 Million Investment in Masimo Corporation $MASI

Norges Bank acquired a new stake in Masimo Corporation (NASDAQ:MASI – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 377,421 shares of the medical equipment provider’s stock, valued at approximately $49,087,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after acquiring an additional 66 shares during the period. Clearstead Advisors LLC boosted its stake in Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73 shares during the period. Hantz Financial Services Inc. grew its holdings in shares of Masimo by 12.9% during the fourth quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 75 shares in the last quarter. Assetmark Inc. raised its stake in Masimo by 5.5% in the fourth quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after purchasing an additional 97 shares in the last quarter. Finally, Orion Porfolio Solutions LLC increased its holdings in shares of Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after buying an additional 104 shares during the last quarter. 85.96% of the stock is owned by institutional investors.

Get Masimo alerts:

Masimo Price Performance

Shares of NASDAQ:MASI opened at $178.82 on Monday. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.00. The company has a market cap of $9.36 billion, a PE ratio of -16.97, a P/E/G ratio of 1.81 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. The stock’s 50-day moving average is $178.45 and its 200 day moving average is $159.41.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on MASI shares. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday, March 18th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research note on Tuesday, February 17th. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a report on Tuesday, February 17th. Finally, Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Nine equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Masimo currently has a consensus rating of “Hold” and an average target price of $180.40.

Get Our Latest Stock Analysis on Masimo

Masimo Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Further Reading

• Five stocks we like better than Masimo
• These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
• 3 Stocks Under $20 to Buy Before a Broader Market Rally
• Petco Faces Tough Competition, But Momentum Is Building
• The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI – Free Report).

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.